These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 17566595)

  • 21. The application of solid dispersion technique with D-mannitol to the improvement in oral absorption of triamterene.
    Arias MJ; Gines JM; Moyano JR; Rabasco AM
    J Drug Target; 1994; 2(1):45-51. PubMed ID: 8069583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions.
    Gao L; Zhang D; Chen M; Duan C; Dai W; Jia L; Zhao W
    Int J Pharm; 2008 May; 355(1-2):321-7. PubMed ID: 18242896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new formulation of fenofibrate: suprabioavailable tablets.
    Guichard JP; Blouquin P; Qing Y
    Curr Med Res Opin; 2000; 16(2):134-8. PubMed ID: 10893657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement the oral bioavailability of praziquantel by incorporation into solid lipid nanoparticles.
    Yang L; Geng Y; Li H; Zhang Y; You J; Chang Y
    Pharmazie; 2009 Feb; 64(2):86-9. PubMed ID: 19320279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A high-throughput approach towards a novel formulation of fenofibrate in omega-3 oil.
    Ratanabanangkoon P; Guzman H; Almarsson O; Berkovitz D; Tokarcyzk S; Straughn AB; Chen H
    Eur J Pharm Sci; 2008 Apr; 33(4-5):351-60. PubMed ID: 18313905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of oral bioavailability of pentoxifylline by solid lipid nanoparticles.
    Varshosaz J; Minayian M; Moazen E
    J Liposome Res; 2010 Jun; 20(2):115-23. PubMed ID: 19694503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A; Hoffman A
    J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation and in vitro/in vivo evaluation of nano-sized crystals for dissolution rate enhancement of ucb-35440-3, a highly dosed poorly water-soluble weak base.
    Hecq J; Deleers M; Fanara D; Vranckx H; Boulanger P; Le Lamer S; Amighi K
    Eur J Pharm Biopharm; 2006 Nov; 64(3):360-8. PubMed ID: 16846725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals.
    Müller RH; Runge S; Ravelli V; Mehnert W; Thünemann AF; Souto EB
    Int J Pharm; 2006 Jul; 317(1):82-9. PubMed ID: 16580159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How do in-vitro release profiles of nanosuspensions from Alzet® pumps correspond to the in-vivo situation? A case study on radiolabeled fenofibrate.
    Hill A; Breyer S; Geissler S; Mier W; Haberkorn U; Weigandt M; Mäder K
    J Control Release; 2013 May; 168(1):77-87. PubMed ID: 23499716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid-based formulations to enhance oral bioavailability of the poorly water-soluble drug anethol trithione: effects of lipid composition and formulation.
    Han SF; Yao TT; Zhang XX; Gan L; Zhu C; Yu HZ; Gan Y
    Int J Pharm; 2009 Sep; 379(1):18-24. PubMed ID: 19508887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A formulation comparison, using a solution and different nanosuspensions of a poorly soluble compound.
    Sigfridsson K; Forssén S; Holländer P; Skantze U; de Verdier J
    Eur J Pharm Biopharm; 2007 Sep; 67(2):540-7. PubMed ID: 17383167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration.
    Luo CF; Yuan M; Chen MS; Liu SM; Zhu L; Huang BY; Liu XW; Xiong W
    Int J Pharm; 2011 May; 410(1-2):138-44. PubMed ID: 21392565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved understanding of the effect of food on drug absorption and bioavailability for lipophilic compounds using an intestinal pig perfusion model.
    Persson EM; Nordgren A; Forsell P; Knutson L; Ohgren C; Forssén S; Lennernäs H; Abrahamsson B
    Eur J Pharm Sci; 2008 May; 34(1):22-9. PubMed ID: 18387789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and characterization of an orodispersible film containing drug nanoparticles.
    Shen BD; Shen CY; Yuan XD; Bai JX; Lv QY; Xu H; Dai L; Yu C; Han J; Yuan HL
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1348-56. PubMed ID: 24103635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo evaluation of silybin nanosuspensions for oral and intravenous delivery.
    Wang Y; Zhang D; Liu Z; Liu G; Duan C; Jia L; Feng F; Zhang X; Shi Y; Zhang Q
    Nanotechnology; 2010 Apr; 21(15):155104. PubMed ID: 20332565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid--an emerging platform for oral delivery of drugs with poor bioavailability.
    Chakraborty S; Shukla D; Mishra B; Singh S
    Eur J Pharm Biopharm; 2009 Sep; 73(1):1-15. PubMed ID: 19505572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suspensions for intravenous (IV) injection: a review of development, preclinical and clinical aspects.
    Wong J; Brugger A; Khare A; Chaubal M; Papadopoulos P; Rabinow B; Kipp J; Ning J
    Adv Drug Deliv Rev; 2008 May; 60(8):939-54. PubMed ID: 18343527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems.
    Cui J; Yu B; Zhao Y; Zhu W; Li H; Lou H; Zhai G
    Int J Pharm; 2009 Apr; 371(1-2):148-55. PubMed ID: 19124065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
    Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.